Literature DB >> 510566

Relationship of weight to successful induction of ovulation with clomiphene citrate.

M K Shepard, J P Balmaceda, C G Leija.   

Abstract

Over a 6 1/2-year period, 117 patients who were anovulatory, euthyroid, and estrogen-primed were treated with clomiphene citrate. Graduated doses from 50 mg to 250 mg daily for 5 days were used to induce ovulation. Of 62 patients who completed treatment, 50 ovulated and 12 did not. Several factors, including age, duration of infertility, weight, previous menstrual history, previous pregnancy history, and previous use of oral contraceptives, were investigated to determine conditions which might influence response. Only weight was found to be significantly different between responders and nonresponders. Furthermore, there was a linear relationship between body weight and dose of clomiphene required to induce ovulation. The ovulation rate for those completing therapy was 81% with a pregnancy rate of 76% of the total and 94% of those ovulating. Population homogeneity with anovulation as the major cause of infertility appears to be the most plausible explanation for the high pregnancy rate.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 510566     DOI: 10.1016/s0015-0282(16)44411-0

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  11 in total

1.  True and sham acupuncture produced similar frequency of ovulation and improved LH to FSH ratios in women with polycystic ovary syndrome.

Authors:  Lisa M Pastore; Christopher D Williams; Jeffrey Jenkins; James T Patrie
Journal:  J Clin Endocrinol Metab       Date:  2011-08-03       Impact factor: 5.958

Review 2.  Ovarian manipulation in ART: going beyond physiological standards to provide best clinical outcomes.

Authors:  Israel Ortega; Juan A García-Velasco; Antonio Pellicer
Journal:  J Assist Reprod Genet       Date:  2018-07-28       Impact factor: 3.412

3.  Human chorionic gonadotropin (hCG) plasma levels at oocyte retrieval and IVF outcomes.

Authors:  R Matorras; A Meabe; R Mendoza; B Prieto; O Ramón; J Mugica; F Aspichueta; A Exposito
Journal:  J Assist Reprod Genet       Date:  2012-07-20       Impact factor: 3.412

4.  Does body mass index of infertile women have an impact on IVF procedure and outcome?

Authors:  C Wittemer; J Ohl; M Bailly; K Bettahar-Lebugle; I Nisand
Journal:  J Assist Reprod Genet       Date:  2000-11       Impact factor: 3.412

5.  Polycystic ovary syndrome: an enigma awaiting solution.

Authors:  M Schwartz; P R Gindoff; R Jewelewicz
Journal:  Bull N Y Acad Med       Date:  1987-03

6.  Resistin levels of serum and follicular fluid in non-obese patients with polycystic ovary syndrome during IVF cycles.

Authors:  Xiu-E Lu; He-Feng Huang; Mei-Gen Li; Yi-Min Zhu; Yu-Li Qiang; Min-Yue Dong
Journal:  J Zhejiang Univ Sci B       Date:  2005-09       Impact factor: 3.066

Review 7.  Polycystic ovarian disease (PCOD)--pregnancy rate and outcome in in vitro fertilization.

Authors:  D Bider; D Levran; S Mashiach; I Ben-Shlomo; J Dor
Journal:  J Assist Reprod Genet       Date:  1993-01       Impact factor: 3.412

Review 8.  Polycystic ovarian syndrome: diagnosis and management.

Authors:  Michael T Sheehan
Journal:  Clin Med Res       Date:  2004-02

9.  Elevated body mass index (BMI) does not adversely affect in vitro fertilization outcome in young women.

Authors:  Kurt Martinuzzi; Sarah Ryan; Martha Luna; Alan B Copperman
Journal:  J Assist Reprod Genet       Date:  2008-04-19       Impact factor: 3.412

10.  In vitro fertilization and embryo transfer: an individualized approach to ovulation induction.

Authors:  M L Taymor; M M Seibel; S P Oskowitz; D M Smith; G Lee
Journal:  J In Vitro Fert Embryo Transf       Date:  1985-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.